IL-6 is upregulated in excessive inflammatory conditions in CB2−/− males [24,25] and has been shown to direct hematopoiesis towards a myeloid output where such abnormal myelopoiesis contributes to the upregulation of MDSCs in cancer and inflammation [26,27]. The gene discussed is IL6; the disease is cancer.